Medicare Enrolled
Dr. Stephan Dorkhom, D.O.
Hematology & Oncology · Wayne, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dorkhom from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dorkhom?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dorkhom
Dr. Stephan Dorkhom is a hematology & oncology specialist in Wayne, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. Dorkhom performed 303 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dorkhom received a total of $14,800 from 76 pharmaceutical and/or device companies across 885 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dorkhom is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ 303 Medicare services
$14,800 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗303
Medicare services
Bottom 12% in NJ for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
161 | $136 | $360 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $101 | $285 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
20 | $27 | $68 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $68 | $157 |
| New patient office visit, complex (60-74 min) | 14 | $150 | $598 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $60 | $194 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,800
Total received (2018-2024)
Avg $2,114/year across 7 years
Top 18% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
885
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,281
2023
$2,867
2022
$2,757
2021
$2,130
2020
$2,306
2019
$1,286
2018
$1,173
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$937
E.R. Squibb & Sons, L.L.C.
$152
AstraZeneca Pharmaceuticals LP
$150
Daiichi Sankyo Inc.
$146
Takeda Pharmaceuticals U.S.A., Inc.
$101
Incyte Corporation
$100
GENZYME CORPORATION
$74
Bayer Healthcare Pharmaceuticals Inc.
$70
Janssen Biotech, Inc.
$63
Merck Sharp & Dohme LLC
$62
Eisai Inc.
$52
PharmaEssentia USA Corporation
$47
Astellas Pharma US Inc
$37
PUMA BIOTECHNOLOGY, INC.
$34
EMD Serono, Inc.
$32
Celgene Corporation
$30
Aveo Pharmaceuticals, Inc.
$24
Exelixis Inc.
$21
SERVIER PHARMACEUTICALS LLC
$18
Alexion Pharmaceuticals, Inc.
$16
ABBVIE INC.
$16
Mirati Therapeutics, Inc.
$15
Regeneron Healthcare Solutions, Inc.
$15
BeiGene USA, Inc.
$15
SOBI, INC
$14
Genentech USA, Inc.
$14
Blueprint Medicines Corporation
$14
TAIHO ONCOLOGY, INC.
$13
Top 3 companies account for 54.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,933
AstraZeneca Pharmaceuticals LP
$1,703
Daiichi Sankyo Inc.
$1,007
Janssen Biotech, Inc.
$989
E.R. Squibb & Sons, L.L.C.
$853
Amgen Inc.
$744
PFIZER INC.
$602
Incyte Corporation
$597
Merck Sharp & Dohme Corporation
$568
Celgene Corporation
$508
Merck Sharp & Dohme LLC
$499
Astellas Pharma US Inc
$490
Eisai Inc.
$363
Bayer HealthCare Pharmaceuticals Inc.
$312
Bayer Healthcare Pharmaceuticals Inc.
$276
Genentech USA, Inc.
$228
AVEO Pharmaceuticals, Inc.
$228
Lilly USA, LLC
$223
EMD Serono, Inc.
$186
Seagen Inc.
$178
GENZYME CORPORATION
$165
Pharmacyclics LLC, An AbbVie Company
$150
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Takeda Pharmaceuticals U.S.A., Inc.
$132
Dendreon Pharmaceuticals LLC
$121
EISAI INC.
$109
Regeneron Healthcare Solutions, Inc.
$82
Global Blood Therapeutics, Inc.
$69
Janssen Products, LP
$65
Foundation Medicine, Inc.
$63
TerSera Therapeutics LLC
$59
ARRAY BIOPHARMA INC
$56
CTI BioPharma Corp.
$55
Epizyme, Inc.,
$50
PUMA BIOTECHNOLOGY, INC.
$49
Teva Pharmaceuticals USA, Inc.
$47
PharmaEssentia USA Corporation
$47
BeiGene USA, Inc.
$45
MEDIVATION FIELD SOLUTIONS LLC
$45
Mirati Therapeutics, Inc.
$44
GE HealthCare
$43
Pharmacyclics LLC, an AbbVie Company
$39
Karyopharm Therapeutics Inc.
$32
Alexion Pharmaceuticals, Inc.
$31
GE HEALTHCARE
$29
TG THERAPEUTICS, INC.
$28
Blueprint Medicines Corporation
$28
Gilead Sciences, Inc.
$28
Myovant Sciences Inc.
$26
Rigel Pharmaceuticals, Inc.
$25
G1 Therapeutics, Inc.
$24
Aveo Pharmaceuticals, Inc.
$24
Janssen Scientific Affairs, LLC
$23
Exelixis Inc.
$21
SERVIER PHARMACEUTICALS LLC
$18
Sumitomo Pharma America, Inc.
$17
Pharmacosmos Therapeutics Inc.
$17
Deciphera Pharmaceuticals Inc.
$16
ABBVIE INC.
$16
Duchesnay USA Incorporated
$15
Progenics Pharmaceuticals, Inc.
$15
Mylan Institutional Inc.
$15
SOBI, INC
$14
Jazz Pharmaceuticals Inc.
$14
JAZZ PHARMACEUTICALS INC.
$14
TG Therapeutics, Inc.
$14
AMAG Pharmaceuticals, Inc.
$14
ImmunoGen, Inc.
$14
TAIHO ONCOLOGY, INC.
$13
EUSA Pharma (US) LLC
$13
Secura Bio, Inc.
$13
Acceleron Pharma, Inc.
$13
Tactile Systems Technology Inc
$12
Octapharma USA, Inc.
$12
Janssen Pharmaceuticals, Inc
$11
Sun Pharmaceutical Industries Inc.
$11
Top 3 companies account for 31.4% of all-time payments
Associated products mentioned in payments ›
ALIMTA · ALUNBRIG · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Aliqopa · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · DARZALEX · ELITEK · ENHERTU · ERBITUX · ERLEADA · Elahere · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · FULPHILA · Fabhalta · Flexitouch Plus · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MEKTOVI · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · PADCEV · PIQRAY · PROMACTA · PROVENGE · PYLARIFY · Padcev · Perjeta · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Reblozyl · SARCLISA · SCEMBLIX · Siklos · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · Tavalisse · Tecentriq · Truxima · Turalio · UKONIQ · ULTOMIRIS · VERZENIO · VONJO · Vectibix · Vitrakvi · Vonjo · WILATE · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · ZEPZELCA · ZOLADEX · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
566
County median income
$87,137
Nearest hospital to ZIP centroid (approximate)
CHILTON MEDICAL CENTER
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dorkhom is a clinical cardiology specialist, with moderate Medicare volume, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dorkhom experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Dorkhom performed 161 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dorkhom receive payments from pharmaceutical companies?
Yes. Dr. Dorkhom received a total of $14,800 from 76 companies across 885 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dorkhom's costs compare to other hematology & oncology specialists in Wayne?
Dr. Dorkhom's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dorkhom) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Wayne
Browse hematology & oncology specialists in Wayne ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology